It is important to note here that anti-MSLN antibodies have frequently been identified to be present in blood samples of patients with mesothelioma and ovarian cancers, thereby advocating MSLN as a valuable immunogenic protein [74]. This evidence concerns the gene MSLN and ovarian carcinoma.